SCHEMBL18871826

SCHEMBL18871826

CC(=O)N1c2ccc(-c3ccc(C(=O)NCCN(C)C)cc3)cc2CC[C@@H]1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 8/20 0.44
▸ PDK2 Q15119 8/20 0.44
▸ PDK3 Q15120 8/20 0.44
▸ PDK4 Q16654 8/20 0.44
▸ MAPT P10636 2/20 0.43
▸ THRB P10828 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ SETD7 Q8WTS6 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ MAPK14 Q16539 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ PDE7A Q13946 1/20 0.41
▸ NAMPT P43490 1/20 0.41
▸ IKBKB O14920 1/20 0.41
▸ PIK3CA P42336 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ PIK3CG P48736 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18871776 0.89 NPC1 (0.44) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL18871841 0.88 NPC1 (0.43) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL18871830 0.87 MAPK14 (0.47) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL18872014 0.86 PDK1 (0.43) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL26072650 0.86 WDR5 (0.42) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL27266042 0.85 DRD2 (0.42) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL18871986 0.85 PDK1 (0.42) PDK1PDK2PDK3PDK4TP53
SCHEMBL18872001 0.83 NAMPT (0.41) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL18871818 0.83 CD274 (0.42) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL18871784 0.82 TP53 (0.49) MAPTTHRBTP53ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3168213-B1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE LLC (US) 2018-08-01 — — EP disclosed
EP-3168213-A1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS Glaxosmithkline LLC (US) 2017-05-17 — — EP disclosed
Send feedback